MARKET

EXAS

EXAS

EXACT Sci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

85.17
-0.13
-0.15%
After Hours: 85.17 0 0.00% 17:35 12/11 EST
OPEN
85.30
PREV CLOSE
85.30
HIGH
85.76
LOW
83.99
VOLUME
1.14M
TURNOVER
--
52 WEEK HIGH
123.99
52 WEEK LOW
53.06
MARKET CAP
12.54B
P/E (TTM)
-49.9121
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EXAS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EXAS News

  • Biotech is beating health care by double this year—here's how one investor would play it
  • CNBC.com.1d ago
  • Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS)
  • Insider Monkey.12/05 01:35
  • Dr. David Ahlquist, co-inventor of Cologuard, named a Fellow of the National Academy of Inventors
  • PR Newswire.12/04 21:30
  • High Growth Non-Invasive Cancer Test Technology: Guardant Health Vs. Exact Sciences
  • Seeking Alpha - Article.12/02 21:37

More

Industry

Biotechnology & Medical Research
-0.34%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About EXAS

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) or other scan.
More

Webull offers EXACT Sciences Corporation (EXAS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.